Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115414
Status:
COMPLETED
Last Update Posted:
2008-08-01
First Post:
2005-06-22
Brief Title:
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy TAC
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20020778
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Global Development Leader
Old Organization:
Amgen Inc